Literature DB >> 12199731

Sodium methohexital (brevital) as an anesthetic in the Wada test.

Henry A Buchtel1, Erasmo A Passaro, Linda M Selwa, John Deveikis, Diana Gomez-Hassan.   

Abstract

PURPOSES: We report our experience with sodium methohexital (Brevital) as an anesthetic used in the Wada test for language and memory in 86 epilepsy surgery patients (173 procedures).
METHODS: The methods are compared with those of the more commonly used anesthetic sodium amobarbital (Amytal).
RESULTS: Despite differences between the methohexital and amobarbital test protocols, the behavioral and neurologic effects of the two anesthetics are similar. Because of the brief duration of methohexital, two successive injections are made on each side rather than one, to lengthen the time available for testing both language and memory. Behavioral and EEG indices return to baseline more quickly and more completely with methohexital than with amobarbital, allowing several repetitions of the procedure without incremental drowsiness, and the total time taken for the procedure is less with methohexital than with amobarbital.
CONCLUSIONS: The results of language and memory testing in the Wada test are equivalent for amobarbital and methohexital, except that methohexital has a briefer duration of action and is associated with less sedation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199731     DOI: 10.1046/j.1528-1157.2002.00902.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Methods for determination of language dominance: the Wada test and proposed noninvasive alternatives.

Authors:  Bassel Abou-Khalil
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

2.  Quantitative EEG is an objective, sensitive, and reliable indicator of transient anesthetic effects during Wada tests.

Authors:  Bin Tu; Nadege J Assassi; Carl W Bazil; Marla J Hamberger; Lawrence J Hirsch
Journal:  J Clin Neurophysiol       Date:  2015-04       Impact factor: 2.177

3.  Feasibility of the superselective test with propofol for determining eloquent brain regions in the endovascular treatment of arteriovenous malformations.

Authors:  José A Jordán González; Juan Carlos Llibre Guerra; José A Prince López; Frank Vázquez Luna; Raúl Marino Rodríguez Ramos; José Carlos Ugarte Suárez
Journal:  Interv Neuroradiol       Date:  2013-09-26       Impact factor: 1.610

4.  Bilateral bispectral index monitoring during suppression of unilateral hemispheric function.

Authors:  Haren Heller; Raheleh Hatami; Paul Mullin; Robert R Sciacca; Alexander G Khandji; Marla Hamberger; Ronald Emerson; Eric J Heyer
Journal:  Anesth Analg       Date:  2005-07       Impact factor: 5.108

5.  Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures.

Authors:  C E Feliciano; R de León-Berra; M S Hernández-Gaitán; H M Torres; O Creagh; R Rodríguez-Mercado
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-05       Impact factor: 3.825

6.  Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy.

Authors:  Marta Szantroch; Aleksandra Bala; Andrzej Rysz; Jarosław Żyłkowski; Andrzej Marchel
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

7.  Methohexital - Induced lateralized periodic discharges during Wada test.

Authors:  Omar A Danoun; Nicholas Beimer; Henry Buchtel; Simon Glynn; David Harris
Journal:  Clin Neurophysiol Pract       Date:  2021-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.